Beijing Beilu Pharmaceutical Co Ltd banner
B

Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016

Watchlist Manager
Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
Watchlist
Price: 10.36 CNY -0.96% Market Closed
Market Cap: ¥5.8B

Beijing Beilu Pharmaceutical Co Ltd
Investor Relations

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of contrast agents, and central nervous system and hypoglycemic drugs. The company is headquartered in Beijing, Beijing and currently employs 905 full-time employees. The company went IPO on 2009-10-30. The Company’s main products include gadopentetate dimeglumine injection, iohexol injection, Iodoparol injection, Iodixanol injection, ferric ammonium citrate effervescent granules, repaglinide tablets, glimepiride tablets, Jiuwei Zhenxin granules, among others. The firm mainly distributes its products in domestic market.

Show more
Loading
300016
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Xu Wang
Chairman & GM
No Bio Available
Ms. Ni Zeng CPA
Deputy GM, Financial Director & Non-Independent Director
No Bio Available
Mr. Sen Li
Executive VP & COO
No Bio Available
Ms. Li Zong
Deputy GM & Director
No Bio Available
Ms. Zehui Shao
Deputy GM, Secretary of the Board of Directors & Non-Independent Director
No Bio Available
Mr. Gen Chang Zheng
Chief Engineer & Employee Representative Member of Supervisory Board
No Bio Available

Contacts

Address
BEIJING
Beijing
7F, Block A, Maples International Office, No. 32, Xizhimen North Street, Haidian District
Contacts
+861062625287
www.beilu.com.cn
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett